Daclatasvir Plus Sofosbuvir Plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients With HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis

被引：0

作者：

Hezode, Christophe

Dore, Gregory J.

Pianko, Stephen

Pol, Stanislas

Stuart, Katherine

Thompson, Alexander

Tse, Edmund

Bhore, Rafia

Jimenez-Exposito, Maria Jesus

机构：

来源：

GASTROENTEROLOGY | 2016年 / 150卷 / 04期

关键词：

D O I：

10.1016/S0016-5085(16)33701-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Su1424

引用

页码：S1096 / S1096

页数：1

共 50 条

[31] MODELING PREDICTS CLINICALLY MEANINGFUL SVR RATES IN GENOTYPE 1 TREATMENT-EXPERIENCED PATIENTS BASED ON RESULTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS TREATED WITH SOFOSBUVIR plus PEGINTERFERON plus RIBAVIRIN FOR 12 WEEKS [J].

Muir, A. ;

Nelson, D. R. ;

Gordon, S. C. ;

Feld, J. J. ;

Patel, K. ;

Lawitz, E. ;

Sheikh, A. M. ;

Brainard, D. M. ;

Symonds, W. T. ;

McHutchison, J. G. ;

Bekele, B. N. ;

Mangia, A. ;

Gane, E. J. .

JOURNAL OF HEPATOLOGY, 2014, 60 (01) :S495-S495

[32] Compare the Efficacy of Sofosbuvir Plus Ribavirin Verus Sofosbuvir Plus Daclatasvir in Patients with Chronic C Hepatitis Genotype 2 Infection [J].

Chang, Kuo-Chin ;

Hu, Tsung-Hui ;

Chen, Chien Hung ;

Wang, Jing-Houng .

HEPATOLOGY, 2018, 68 :586A-586A

[33] Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease [J].

Charlton, Michael ;

Everson, Gregory T. ;

Flamm, Steven L. ;

Kumar, Princy ;

Landis, Charles ;

Brown, Robert S., Jr. ;

Fried, Michael W. ;

Terrault, Norah A. ;

O'Leary, Jacqueline G. ;

Vargas, Hugo E. ;

Kuo, Alexander ;

Schiff, Eugene ;

Sulkowski, Mark S. ;

Gilroy, Richard ;

Watt, Kymberly D. ;

Brown, Kimberly ;

Kwo, Paul ;

Pungpapong, Surakit ;

Korenblat, Kevin M. ;

Muir, Andrew J. ;

Teperman, Lewis ;

Fontana, Robert J. ;

Denning, Jill ;

Arterburn, Sarah ;

Dvory-Sobol, Hadas ;

Brandt-Sarif, Theo ;

Pang, Phillip S. ;

McHutchison, John G. ;

Reddy, K. Rajender ;

Afdhal, Nezam .

GASTROENTEROLOGY, 2015, 149 (03) :649-659

[34] Circulating microRNAs as predictors of response to sofosbuvir plus daclatasvir plus ribavirin in in HCV genotype-4 Egyptian patients [J].

Hassuna, Noha Anwar ;

Gamil, Aya Nabil ;

Mahmoud, Mahmoud Shokry ;

Mohamed, Wafaa Khairy ;

Khairy, Rasha .

BMC GASTROENTEROLOGY, 2022, 22 (01)

[35] Sofosbuvir plus Ribavirin in the Treatment of Chronic HCV Genotype 4 Infection in Patients of Egyptian Ancestry [J].

Ruane, Peter J. ;

Ain, Dani ;

Riad, Joseph ;

Meshrekey, Raymond G. ;

Stryker, Richard ;

Wolfe, Peter R. ;

Basilyous, Lamese R. ;

Jiang, Deyuan ;

Knox, Steven J. ;

Kersey, Kathryn ;

Symonds, William T. .

HEPATOLOGY, 2013, 58 :736A-736A

[36] Daclatasvir exposure does not explain lower sustained virologic response rates in cirrhotic patients with HCV genotype 3 following 12 weeks of daclatasvir plus sofosbuvir treatment [J].

Eley, Timothy ;

Wang, Reena ;

Huang, Shu-Pang ;

Gandhi, Yash ;

Cirincione, Brenda ;

LaCreta, Frank ;

Garimella, Tushar .

HEPATOLOGY, 2015, 62 :567A-568A

[37] DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 3 INFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM [J].

Hezode, C. ;

De Ledinghen, V. ;

Fontaine, H. ;

Zoulim, F. ;

Lebray, P. ;

Boyer, N. ;

Larrey, D. ;

Silvain, C. ;

Botta-Fridlund, D. ;

Leroy, V. ;

Bourliere, M. ;

D'Alteroche, L. ;

Hubert-Fouchard, I. ;

Guyader, D. ;

Rosa, I. ;

Nguyen-Khac, E. ;

Di Martino, V. ;

Carrat, F. ;

Fedchuk, L. ;

Akremi, R. ;

Bennai, Y. ;

Bronowicki, J. -P. .

JOURNAL OF HEPATOLOGY, 2015, 62 :S265-S266

[38] Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: interim analysis of a French multicenter compassionate use program [J].

Hezode, C. ;

De Ledinghen, V. ;

Fontaine, H. ;

Zoulim, F. ;

Lebray, P. ;

Boyer, N. ;

Dominique, L. ;

Silvain, C. ;

Botta-Fridlund, D. ;

Leroy, V. ;

Bourliere, M. ;

D'alteroche, L. ;

Hubert-Fouchard, I. ;

Guyader, D. ;

Rosa, I. ;

Nguyen-Khac, E. ;

Di Martino, V. ;

Carrat, F. ;

Fedchuk, L. ;

Akremi, R. ;

Bennai, Y. ;

Bronowicki, J. .

JOURNAL OF VIRAL HEPATITIS, 2015, 22 :29-29

[39] An integrated safety analysis of daclatasvir plus sofosbuvir, with or without ribavirin, in patients with chronic HCV infection [J].

Landis, Charles S. ;

Nelson, David R. ;

Sulkowski, Mark S. ;

Ruane, Peter J. ;

Mills, Anthony M. ;

Poordad, Fred ;

Wyles, David L. ;

Bhore, Rafia ;

Ackerman, Peter ;

Rana, Khurram ;

Swenson, Eugene S. ;

Noviello, Stephanie .

HEPATOLOGY, 2015, 62 :565A-565A

[40] Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience [J].

G. Shiha ;

R. Soliman ;

M. ElBasiony ;

A. A. Hassan ;

N. N. H. Mikhail .

Hepatology International, 2018, 12 :339-347

← 1 2 3 4 5 →